Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome
Haishan Lin,1
Ernestine Lee,1
Kevin Hestir,1
Cindy Leo,1
Minmei Huang,1
Elizabeth Bosch,1
Robert Halenbeck,1
Ge Wu,1
Aileen Zhou,1
Dirk Behrens,1
Diane Hollenbaugh,1*
Thomas Linnemann,1
Minmin Qin,1
Justin Wong,1
Keting Chu,1
Stephen K. Doberstein,1
Lewis T. Williams1,2
Abstract:
To understand the system of secreted proteins and receptorsinvolved in cell-cell signaling, we produced a comprehensiveset of recombinant secreted proteins and the extracellular domainsof transmembrane proteins, which constitute most of the proteincomponents of the extracellular space. Each protein was testedin a suite of assays that measured metabolic, growth, or transcriptionalresponses in diverse cell types. The pattern of responses acrossassays was analyzed for the degree of functional selectivityof each protein. One of the highly selective proteins was apreviously undescribed ligand, designated interleukin-34 (IL-34),which stimulates monocyte viability but does not affect responsesin a wide spectrum of other assays. In a separate functionalscreen, we used a collection of extracellular domains of transmembraneproteins to discover the receptor for IL-34, which was a knowncytokine receptor, colony-stimulating factor 1 (also calledmacrophage colony-stimulating factor) receptor. This systematicapproach is thus useful for discovering new ligands and receptorsand assessing the functional selectivity of extracellular regulatoryproteins.
1 Five Prime Therapeutics, Inc., 1650 Owens Street, Suite 200, San Francisco, CA 94158, USA. 2 School of Medicine, University of California, San Francisco, CA 94143, USA.
* Present address: Schering-Plough Biopharma, Palo Alto, CA 94304,USA.
Present address: DigitAB, Inc., Burlingame, CA 94010, USA.
To whom correspondence should be addressed. E-mail: rusty.williams{at}fiveprime.com
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (13 May 2008) Sci. Signal.1 (19), ec179.
[DOI: 10.1126/stke.119ec179] |Abstract »|Correction »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes.
F. Ciccia, R. Alessandro, V. Rodolico, G. Guggino, S. Raimondo, C. Guarnotta, A. Giardina, G. Sireci, G. Campisi, G. De Leo, et al. (2013)
Rheumatology
52, 1009-1017
|Abstract »|Full Text »|PDF »
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer.
J. Xu, J. Escamilla, S. Mok, J. David, S. Priceman, B. West, G. Bollag, W. McBride, and L. Wu (2013)
Cancer Res.
73, 2782-2794
|Abstract »|Full Text »|PDF »
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor.
C. Zhang, P. N. Ibrahim, J. Zhang, E. A. Burton, G. Habets, Y. Zhang, B. Powell, B. L. West, B. Matusow, G. Tsang, et al. (2013)
PNAS
110, 5689-5694
|Abstract »|Full Text »|PDF »
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.
J. Luo, F. Elwood, M. Britschgi, S. Villeda, H. Zhang, Z. Ding, L. Zhu, H. Alabsi, R. Getachew, R. Narasimhan, et al. (2013)
J. Exp. Med.
210, 157-172
|Abstract »|Full Text »|PDF »
Increased Serum Interleukin-34 in Patients with Coronary Artery Disease.
Z. Li, D. Jin, Y. Wu, K. Zhang, P. Hu, X. Cao, and Z. Chen (2012)
Journal of International Medical Research
40, 1866-1870
|Abstract »|Full Text »|PDF »
Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth.
F. Harbinski, V. J. Craig, S. Sanghavi, D. Jeffery, L. Liu, K. A. Sheppard, S. Wagner, C. Stamm, A. Buness, C. Chatenay-Rivauday, et al. (2012)
Cancer Discovery
2, 948-959
|Abstract »|Full Text »|PDF »
The molecular profile of microglia under the influence of glioma.
The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).
L. van der Heijden, C. L. M. H. Gibbons, P. D. S. Dijkstra, J. R. Kroep, C. S. P. van Rijswijk, R. A. Nout, K. M. Bradley, N. A. Athanasou, P. C. W. Hogendoorn, and M. A. J. van de Sande (2012)
Bone Joint J
94-B, 882-888
|Abstract »|Full Text »|PDF »
Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.
Y. Nakamichi, T. Mizoguchi, A. Arai, Y. Kobayashi, M. Sato, J. M. Penninger, H. Yasuda, S. Kato, H. F. DeLuca, T. Suda, et al. (2012)
PNAS
109, 10006-10011
|Abstract »|Full Text »|PDF »
Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
A. Arai, T. Mizoguchi, S. Harada, Y. Kobayashi, Y. Nakamichi, H. Yasuda, J. M. Penninger, K. Yamada, N. Udagawa, and N. Takahashi (2012)
J. Cell Sci.
125, 2910-2917
|Abstract »|Full Text »|PDF »
Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages.
G. Hoeffel, Y. Wang, M. Greter, P. See, P. Teo, B. Malleret, M. Leboeuf, D. Low, G. Oller, F. Almeida, et al. (2012)
J. Exp. Med.
209, 1167-1181
|Abstract »|Full Text »|PDF »
Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807.
W. Yu, J. Chen, Y. Xiong, F. J. Pixley, Y.-G. Yeung, and E. R. Stanley (2012)
J. Biol. Chem.
287, 13694-13704
|Abstract »|Full Text »|PDF »
T. Chihara, M. Hashimoto, A. Osman, Y. Hiyoshi-Yoshidomi, I. Suzu, N. Chutiwitoonchai, M. Hiyoshi, S. Okada, and S. Suzu (2012)
J. Immunol.
188, 3620-3627
|Abstract »|Full Text »|PDF »
Aptamers and the RNA World, Past and Present.
L. Gold, N. Janjic, T. Jarvis, D. Schneider, J. J. Walker, S. K. Wilcox, and D. Zichi (2012)
Cold Spring Harb Perspect Biol
4, a003582
|Abstract »|Full Text »|PDF »
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.
Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients.
M. Chemel, B. Le Goff, R. Brion, C. Cozic, M. Berreur, J. Amiaud, G. Bougras, S. Touchais, F. Blanchard, M. F. Heymann, et al. (2012)
Ann Rheum Dis
71, 150-154
|Abstract »|Full Text »|PDF »
Structural insights into the extracellular assembly of the hematopoietic Flt3 signaling complex.
K. Verstraete, G. Vandriessche, M. Januar, J. Elegheert, A. V. Shkumatov, A. Desfosses, K. Van Craenenbroeck, D. I. Svergun, I. Gutsche, B. Vergauwen, et al. (2011)
Blood
118, 60-68
|Abstract »|Full Text »|PDF »
The mononuclear phagocyte system of the pig as a model for understanding human innate immunity and disease.
L. Fairbairn, R. Kapetanovic, D. P. Sester, and D. A. Hume (2011)
J. Leukoc. Biol.
89, 855-871
|Abstract »|Full Text »|PDF »
Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.
D. Hashimoto, A. Chow, M. Greter, Y. Saenger, W.-H. Kwan, M. Leboeuf, F. Ginhoux, J. C. Ochando, Y. Kunisaki, N. van Rooijen, et al. (2011)
J. Exp. Med.
208, 1069-1082
|Abstract »|Full Text »|PDF »
Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity.
BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation.
R. B. Corcoran, D. Dias-Santagata, K. Bergethon, A. J. Iafrate, J. Settleman, and J. A. Engelman (2010)
Science Signaling
3, ra84
|Abstract »|Full Text »|PDF »
An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation.
K. P. A. MacDonald, J. S. Palmer, S. Cronau, E. Seppanen, S. Olver, N. C. Raffelt, R. Kuns, A. R. Pettit, A. Clouston, B. Wainwright, et al. (2010)
Blood
116, 3955-3963
|Abstract »|Full Text »|PDF »
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages.
F. Ginhoux, M. Greter, M. Leboeuf, S. Nandi, P. See, S. Gokhan, M. F. Mehler, S. J. Conway, L. G. Ng, E. R. Stanley, et al. (2010)
Science
330, 841-845
|Abstract »|Full Text »|PDF »
Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.
S. Wei, S. Nandi, V. Chitu, Y.-G. Yeung, W. Yu, M. Huang, L. T. Williams, H. Lin, and E. R. Stanley (2010)
J. Leukoc. Biol.
88, 495-505
|Abstract »|Full Text »|PDF »
Editorial: CSF1R, CSF-1, and IL-34, a "menage a trois" conserved across vertebrates.
N. Droin and E. Solary (2010)
J. Leukoc. Biol.
87, 745-747
|Full Text »|PDF »
Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products.
V. Garceau, J. Smith, I. R. Paton, M. Davey, M. A. Fares, D. P. Sester, D. W. Burt, and D. A. Hume (2010)
J. Leukoc. Biol.
87, 753-764
|Abstract »|Full Text »|PDF »
Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency.
R. Gonzalez, L. L. Jennings, M. Knuth, A. P. Orth, H. E. Klock, W. Ou, J. Feuerhelm, M. V. Hull, E. Koesema, Y. Wang, et al. (2010)
PNAS
107, 3552-3557
|Abstract »|Full Text »|PDF »
Development of Monocytes, Macrophages, and Dendritic Cells.
F. Geissmann, M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley (2010)
Science
327, 656-661
|Abstract »|Full Text »|PDF »
Macrophage differentiation of myeloid progenitor cells in response to M-CSF is regulated by the dual-specificity phosphatase DUSP5.
M.-F. Grasset, S. Gobert-Gosse, G. Mouchiroud, and R. P. Bourette (2010)
J. Leukoc. Biol.
87, 127-135
|Abstract »|Full Text »|PDF »
Automation of the SomaLogic Proteomics Assay: A Platform for Biomarker Discovery.
T. R. Keeney, C. Bock, L. Gold, S. Kraemer, B. Lollo, M. Nikrad, M. Stanton, A. Stewart, J. D. Vaught, and J. J. Walker (2009)
Journal of Laboratory Automation
14, 360-366
|Abstract »|Full Text »|PDF »
CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation.
C. Auffray, D. K. Fogg, E. Narni-Mancinelli, B. Senechal, C. Trouillet, N. Saederup, J. Leemput, K. Bigot, L. Campisi, M. Abitbol, et al. (2009)
J. Exp. Med.
206, 595-606
|Abstract »|Full Text »|PDF »
Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages.
K. M. Irvine, M. R. Andrews, M. A. Fernandez-Rojo, K. Schroder, C. J. Burns, S. Su, A. F. Wilks, R. G. Parton, D. A. Hume, and M. J. Sweet (2009)
J. Leukoc. Biol.
85, 278-288
|Abstract »|Full Text »|PDF »
CSF-1 Promoter-Driven IL-34 Expression Can Rescue Phenotypes of CSF-1-Deficient Mice.
S. Wei, H. Lin, and E. R. Stanley (2008)
Blood (ASH Annual Meeting Abstracts)
112, 3867
|Abstract »
IL-34, in Synergy with RANK Ligand, Promotes Osteoclast Development through the CSF-1 Receptor.
M. M. Huang, C. Leo, S. Wei, E. R. Stanley, S. Doberstein, and H. Lin (2008)
Blood (ASH Annual Meeting Abstracts)
112, 5392
|Abstract »